CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024

Cardiol Therapeutics (NASDAQ:CRDL) just reported results for the first quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any conc ...